Pharmac dips toe in the water

Pharmac has made the first tentative steps towards looking at Herceptin funding by agreeing to fund a $3.2 million trial which will compare nine-week and 12-month treatment options.

Some are complaining but at least it is a step in the right direction.

41%
×